Murine hindlimb reperfusion injury can be initiated by a self-reactive monoclonal IgM

被引:53
作者
Austen, WG
Zhang, M
Chan, R
Friend, D
Hechtman, HB
Carroll, MC
Moore, FD
机构
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA
[5] Nat Antibodies Inc, Boston, MA USA
[6] Ctr Blood Res, Boston, MA 02115 USA
[7] Massachusetts Gen Hosp, Boston, MA 02114 USA
关键词
D O I
10.1016/j.surg.2004.05.016
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Murine hindlimb reperfusion injury (I/R), is initiated by activation of the classical pathway of complement. Complement receptor-2 knockout mice (Cr2(-/-)) are protected from I/R injury due to defective B-1 cells with a resulting deficient natural immunoglobulin M (IgM) repertoire. Cr2(-/-) and wild type (WT) mice were studied to isolate the antibody or antibodies responsible for initiation of I/R. Methods. IgM-secreting B-1 cell clones were produced with hybridoma technology from WT cells. Of 21 clones tested in marine I/R models, only 1 clone, CM22, was found to restore injury in protected mice. Cr2(-/-) mice reconstituted with IgM from individual clones, WT serum, or saline were subjected to 2 hours hindlimb ischemia and 3 hours reperfusion and compared with WT Results. Muscle injury in Cr2(-/-) mice reconstituted with CM22 was similar to injury in WT mice reconstituted with saline and CT2(-/-) mice reconstituted with WT serum. This injury was 137% greater (P < .05) than in both Cr2(-/-) mice reconstituted with saline and those reconstituted with a different IgM clone, CM31. IgM and C3 deposition as found only on injured muscle of WT mice or Cr2(-/-) mice reconstituted with CM22 or WT serum. Conclusion. A single clone of self-reactive IgM, CM22, can initiate complement-dependent I/R injury.
引用
收藏
页码:401 / 406
页数:6
相关论文
共 21 条
  • [1] B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection
    Baumgarth, N
    Herman, OC
    Jager, GC
    Brown, LE
    Herzenberg, LA
    Chen, JZ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (02) : 271 - 280
  • [2] Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire
    Fleming, SD
    Shea-Donohue, T
    Guthridge, JM
    Kulik, L
    Waldschmidt, TJ
    Gipson, MG
    Tsokos, GC
    Holers, VM
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (04) : 2126 - 2133
  • [3] Susceptibility alleles for aberrant B-1 cell proliferation involved in spontaneously occurring B-cell chronic lymphocytic leukemia in a model of New Zealand white mice
    Hamano, Y
    Hirose, S
    Ida, A
    Abe, M
    Zhang, DQ
    Kodera, S
    Jiang, Y
    Shirai, J
    Miura, Y
    Nishimura, H
    Shirai, T
    [J]. BLOOD, 1998, 92 (10) : 3772 - 3779
  • [4] Hayakawa K, 2000, CURR TOP MICROBIOL, V252, P15
  • [5] Herzenberg LA, 2000, CURR TOP MICROBIOL, V252, P3
  • [6] HILL J, 1992, J IMMUNOL, V149, P1723
  • [7] MOLECULAR-BASIS OF COMPLEMENT ACTIVATION IN ISCHEMIC MYOCARDIUM - IDENTIFICATION OF SPECIFIC MOLECULES OF MITOCHONDRIAL ORIGIN THAT BIND HUMAN C1Q AND FIX COMPLEMENT
    KAGIYAMA, A
    SAVAGE, HE
    MICHAEL, LH
    HANSON, G
    ENTMAN, ML
    ROSSEN, RD
    [J]. CIRCULATION RESEARCH, 1989, 64 (03) : 607 - 615
  • [8] KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.iy.11.040193.002441
  • [9] NITRIC-OXIDE SYNTHASE IN HUMAN AND RAT LUNG - IMMUNOCYTOCHEMICAL AND HISTOCHEMICAL-LOCALIZATION
    KOBZIK, L
    BREDT, DS
    LOWENSTEIN, CJ
    DRAZEN, J
    GASTON, B
    SUGARBAKER, D
    STAMLER, JS
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1993, 9 (04) : 371 - 377
  • [10] BLOCKADE OF COMPLEMENT ACTIVATION PREVENTS LOCAL AND PULMONARY ALBUMIN LEAK AFTER LOWER TORSO ISCHEMIA REPERFUSION
    LINDSAY, TF
    HILL, J
    ORTIZ, F
    RUDOLPH, A
    VALERI, CR
    HECHTMAN, HB
    MOORE, FD
    [J]. ANNALS OF SURGERY, 1992, 216 (06) : 677 - 683